Needham & Company Raises Price Target on St. Jude Medical (STJ) Following Strong 1Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Needham & Company Raises Price Target on St. Jude Medical (STJ) Following Strong 1Q Results
April 20, 2016 7:15 AM EDT
ST. PAUL, Minn.--(BUSINESS WIRE)--
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company,
today reported sales and net earnings for the first quarter ended April
2, 2016.
First quarter 2016 highlights:
Net sales of $1.448 billion increased 8 percent as reported, or 2
percent on a comparable constant currency basis, at the high end of
the companys guidance range.
St. Jude Medical has successfully completed its integration of
Thoratec; left ventricular assist device (LVAD) sales grew strong
double digits on a comparable constant currency basis....
More
April 19, 2016 8:02 AM EDT
Prominent European electrophysiology labs and hospitals have embraced
the next generation mapping systems automation, flexibility and
precision for tailoring treatment for patients with cardiac arrhythmias
ST. PAUL, Minn.--(BUSINESS WIRE)--
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company,
today announced expansion of its EnSite Precision cardiac mapping
system limited market release in Europe and use of the new platform in
more than 600 cases in nine countries since receiving CE Mark in January
2016. The mapping system is a next-generation platform designed to
provide automation, flexibility and precision for tailored... More
April 18, 2016 8:00 AM EDT
The St. Jude Medical MultiPoint Pacing
technology advances options for clinicians to tailor therapy for heart
failure patients
ST. PAUL, Minn.--(BUSINESS WIRE)--
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company,
recently received U.S. Food and Drug Administration (FDA) approval of
the companys proprietary, first-to-market... More
